Kedalion Therapeutics
Latest round
- Series B
Last raised
- Nov 2021
Total raised
- Undisclosed
Investors
- 2
About Kedalion Therapeutics
Kedalion Therapeutics, Inc.Founded in 2015 and headquartered in Menlo Park, US, Kedalion Therapeutics, Inc. specializes in ophthalmic therapies. The company was founded by Ehud Ivri and Mark Blumenkranz, both of whom have extensive backgrounds in the healthcare sector. In June 2022, Kedalion was acquired by Novartis Pharmaceuticals Corporation for an undisclosed sum. This acquisition is part of Novartis's strategy to enhance its portfolio in ophthalmology.Kedalion Therapeutics, Inc. develops innovative medical solutions in ophthalmology, including its AcuStream™ technology. This electromechanical device facilitates precise dosing and accurate delivery of topical ophthalmic medications.Kedalion's revenue comes primarily through prescription sales of its innovative products, notably facilitated through partnerships with healthcare providers and pharmacies. The sales transactions occur within agreements that ensure direct access to patients in need of their ophthalmic treatments.Moving forward, Kedalion Therapeutics aims to expand its product offerings, focusing on the development of additional ophthalmic delivery systems. The recent acquisition by Novartis is expected to enhance their capabilities in addressing unmet patient needs in front-of-eye conditions. This strategic move aligns with Novartis's goal of growing its ophthalmics portfolio.
Who invested in Kedalion Therapeutics
2 investors across 1 round
See all investors in Kedalion Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 15, 2021
Amount
Undisclosed
Investors
Questions about Kedalion Therapeutics
Who invested in Kedalion Therapeutics?
Kedalion Therapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kedalion Therapeutics raised?
Kedalion Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kedalion Therapeutics last raise money?
Kedalion Therapeutics's most recent round on record is a Series B, in Nov 2021.
What does Kedalion Therapeutics do?
Kedalion Therapeutics is a medical devices & equipment company.
Where is Kedalion Therapeutics headquartered?
Kedalion Therapeutics is headquartered in Menlo Park, US.
Which VCs invest in companies like Kedalion Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Kedalion Therapeutics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Kedalion Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.